Jonathan Spergel

17PUBLICATIONS
54CO-AUTHORS
Behavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Social epidemiologyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 06, 2026
Clinical Trial: Dupilumab Improves Eosinophilic Oesophagitis Outcomes Versus Placebo Regardless of Comorbidities or Treatment History in a Randomised Clinical Trial.

|Mar 03, 2025
Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis.

Amy S Paller, Lawrence F Eichenfield, Alan D Irvine

|Sep 18, 2024
HLA-DR+ regulatory T cells and IL-10 are associated with success or failure of desensitization outcomes.

Xiaoying Zhou, Diane Dunham, Sayantani B Sindher

|Jun 28, 2024
Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.

Jonathan M Spergel, Mirna Chehade, Evan S Dellon

|Apr 25, 2024
Reducing Eosinophil Counts in Eosinophilic Esophagitis in Children Is Associated With Reduction in Later Stricture Development.

Alexandra Strauss Starling, Yue Ren, Hongzhe Li

|May 26, 2023
IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation.

Peyton E Conrey, Lidiya Denu, Kaitlin C O'Boyle

Pageof 3

Frequent Collaborators

5 joint publications

Melanie A Ruffner

3 joint publications

David A Hill

3 joint publications

Amanda Muir

2 joint publications

Terri Brown-Whitehorn